Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin B3 pseudogene 1 (CCNB3P1)
- Target
- CCNB3P1
- Molecular classification
- Other (pseudogene)
01
Overview
Cyclin B3 pseudogene 1 (CCNB3P1) is a non-coding pseudogene related to the protein-coding gene cyclin B3 (CCNB3). Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations, insertions, deletions, or lack of regulatory elements required for expression. They do not encode an active protein product. As such, CCNB3P1 is not regarded as a therapeutic target, receptor, enzyme, transporter, or signaling molecule. There is no substantiated function, disease association, or role as a drug target reported for CCNB3P1 in available genetic or biomedical databases.
- Other names
- Cyclin B3 pseudogene 1CCNB3P1
Beyond the preview
Go deeper on Cyclin B3 pseudogene 1 (CCNB3P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyclin B3 pseudogene 1 (CCNB3P1).